Medical University of Vienna
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Private
- Established
- 1365-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.meduniwien.ac.at
Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases
- First Posted Date
- 2023-05-19
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 20
- Registration Number
- NCT05866432
- Locations
- 🇦🇹
AKH Universitaetsklinikum Vienna, Department f. Internal medicine I, oncology, Vienna, Austria
BCC Excision Revisited
Completed
- Conditions
- Eye CancerEye DiseasesBasal Cell Carcinoma
- First Posted Date
- 2023-05-10
- Last Posted Date
- 2023-05-16
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 451
- Registration Number
- NCT05853315
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Corneal Findings in Patients Treated With Belantamab Mafodotin
Not yet recruiting
- Conditions
- Corneal CystMultiple MyelomaCorneal Diseases
- First Posted Date
- 2023-04-27
- Last Posted Date
- 2023-04-27
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 50
- Registration Number
- NCT05833737
Metacognitive Training in Ultra-high Risk
Not Applicable
Recruiting
- Conditions
- Clinical High Risk for PsychosisAt-risk Mental StateUltra-high Risk for Psychosis
- Interventions
- Behavioral: Metacognitive Training
- First Posted Date
- 2023-04-25
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 30
- Registration Number
- NCT05827900
- Locations
- 🇦🇹
Department of Psychiatry and Psychotherapy, Vienna, Austria
🇦🇹Department of Child and Adolescent Psychiatry, Vienna, Austria
Intraindividual Comparison of EMO IOLs
Not Applicable
Recruiting
- Conditions
- Age Related Cataracts
- Interventions
- Procedure: phacoemulsification and intraocular lens implantation
- First Posted Date
- 2023-04-20
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 311
- Registration Number
- NCT05822089
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Multicentric Prospective T1 Urinary Bladder Cancer Registry
Recruiting
- Conditions
- T1 Urinary Bladder Cancer
- First Posted Date
- 2023-03-30
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 700
- Registration Number
- NCT05792033
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Relevance of Reversible Causes During OHCA (Rebecca Study)
Not Applicable
Recruiting
- Conditions
- Out-Of-Hospital Cardiac ArrestCardiopulmonary Arrest
- Interventions
- Diagnostic Test: Checklist for evaluation of reversible causes
- First Posted Date
- 2023-03-27
- Last Posted Date
- 2023-07-25
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 100
- Registration Number
- NCT05784480
- Locations
- 🇦🇹
Anesthesiology and Intensive Care Medicine Department - Medical University of Vienna, Vienna, Austria
🇦🇹Department of Anesthesia, General Intensive Care and Pain Management,Medical University of Vienna, Vienna, Austria
ERILs Und SNILs Unter SOC
Not Applicable
Withdrawn
- Conditions
- Stroke, Acute
- Interventions
- Diagnostic Test: diffusion-weighted magnetic resonance imaging
- First Posted Date
- 2023-03-27
- Last Posted Date
- 2023-03-27
- Lead Sponsor
- Medical University of Vienna
- Registration Number
- NCT05786170
Detection of Acetylsalicylic Acid and Omega-3 Fatty Acids in Schirmers' Test Strips Using Mass Spectrometry
Phase 2
Completed
- Conditions
- Dry Eye
- Interventions
- Drug: Aspirin 500Mg TabDietary Supplement: Dr. Böhm® Omega 3 complex 870 mg
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2023-03-20
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 32
- Registration Number
- NCT05775536
- Locations
- 🇦🇹
Medical University of Vienna, Department of Clinical Pharmacology, Vienna, Austria
Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years
Phase 4
Not yet recruiting
- Conditions
- COVID-19Pneumococcal Infections
- Interventions
- Biological: NVXBiological: PlaceboBiological: PCV20
- First Posted Date
- 2023-03-14
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 256
- Registration Number
- NCT05767606
© Copyright 2025. All Rights Reserved by MedPath